|
| A Zisman, D Leibovici, YI Siegel and A Lindner; Zerifin, Israel. (Presented by Dr. Zisman) |
Introduction and Objectives:
The study aim was to monitor and assess morbidity associated with the process of transrectal ultrasound guided prostate biopsy (TRUSgBx). |
Methods:
98 consecutive biopsies were enrolled. A questionnaire was filled in 3 consecutive appointments. Patients mean age was 67±9 years. The PSA median was 8.2 ng/ml.. CAP was diagnosed in 27% of cases. The mean Gleason's score was 6.4±1.5. Patients were given prophylactic antibiotic treatment starting 24h' before the biopsy (89% quinolones and 10% cephalosporin). |
Results:
Before biopsy: 9% of the patients attributed a sexual impairment resulting from anticipation for the biopsy scheduled. 65% of patients reported anxiety prior to biopsy, leading to the use of a anxiolytic agent in 5.3%. During biopsy: 96% and 86% of the patients reported pain and discomfort, respectively: mild in 42% and 28% and severe in 16% and 30%, respectively. |
| Half of the patients reported pain and discomfort different from what they expected, in Two thirds it was less than they expected. After the biopsy: 48% and 21% of patients, respectively, reported pelvic pain lasting 1-2 days. 14% used analgesic agents. 50% of the patients were still employed. A total sum of 25 working days were lost by 22% of the patients who were still employed. 58% reported hematuria starting immediately and subsiding after 5.6±7.7 days. |
| Hematospermia was reported by 51% and continued for 13.2±12.4 days. Rectal bleeding was reported by 40% and continued for 2.1±1.8 days. 25% of the patients reported mild voiding difficulties and additional 4.5% presented with acute urinary retention. 5 patients had fever (38.5±1.03) resulting in admission in 4(4.2%). One of these patients had severe sepsis. 21% and 20% of the patients reported sexual impairment and decreased libido, respectively. 75% of the patients reported anxiety during the period awaiting for the histological report, mandating the use of anxiolytic agents in 13%. |
Conclusions:
Prostate biopsy commonly causes a vast variety of complications and has a substantial impact on the patients well being. |
| Source of Funding: Departmental. |
| Source: 1999 AUA Meeting |
.........................................................................................
We're sorry you are having to learn about prostatitis, but we're glad you came here, because we think we can help. Please be advised that the Prostatitis Foundation does
not warrant, support, sponsor, endorse, recommend or accept responsibility for any health care provider or any treatment or protocol performed by any heath care provider.
© The
Prostatitis Foundation
.........................................................................................
|
